Zimmer Biomet Holdings, Inc. (ZBH)
| Market Cap | 20.87B |
| Revenue (ttm) | 7.68B |
| Net Income (ttm) | 903.80M |
| Shares Out | 199.04M |
| EPS (ttm) | 4.43 |
| PE Ratio | 23.66 |
| Forward PE | 12.75 |
| Dividend | $0.96 (0.92%) |
| Ex-Dividend Date | Dec 30, 2024 |
| Volume | 2,132,089 |
| Open | 103.16 |
| Previous Close | 103.63 |
| Day's Range | 102.86 - 105.08 |
| 52-Week Range | 97.69 - 133.90 |
| Beta | 1.02 |
| Analysts | Hold |
| Price Target | 124.43 (+18.7%) |
| Earnings Date | Feb 6, 2025 |
About ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]
Financial Performance
In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.
Financial StatementsAnalyst Forecast
According to 23 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is $124.43, which is an increase of 18.70% from the latest price.
News
Zimmer Biomet: Adding To The Growth Profile
Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 drug overhang. The 2015 Zimmer Biomet merger hasn't been fully delivered, but ...
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
On Thursday, Zimmer Biomet Holdings, Inc ZBH reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30.
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants David DeMartino - Senior Vice President-Investor Relations Ivan Tornos - Pres...
Zimmer Biomet forecasts 2025 profit below estimates
Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it anticipates a hit from a strong dollar.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.
NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquisi...
PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc....
Zimmer Biomet to buy Paragon 28 for $1.1 billion
Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion.
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results
WARSAW, Ind., Jan. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6, 2025 a...
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
Zimmer Biomet Holdings (ZBH) is expanding its product portfolio and improving cash flow, positioning it for long-term profitability and financial health. ZBH is undervalued compared to peers, with sig...
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WARSAW, Ind. , Dec. 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J....
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
WARSAW, Ind. , Dec. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technol...
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
A Total Knee Replacement Alternative for Patients with Metal and/or Bone Cement Sensitivities WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medi...
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Appr...
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
WARSAW, Ind. , Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Heal...
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
WARSAW, Ind., and ZURICH , Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision...
Arnold Schwarzenegger partners with Zimmer Biomet as chief movement officer
Arnold Schwarzenegger, former governor of California, and Ivan Tornos, president and CEO of Zimmer Biomet, join CNBC's 'Power Lunch' to discuss their partnership in promoting orthopedic health, how Zi...
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World WARSAW,...
Zimmer Biomet to Present at Jefferies London Healthcare Conference
WARSAW, Ind. , Nov. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London ...
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
On Wednesday, Zimmer Biomet Holdings, Inc ZBH reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates.
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants David DeMartino – Senior Vice President-Investor Relations Ivan Tornos – Pres...
Implant maker Zimmer Biomet lowers full-year profit forecast
Hip implant maker Zimmer Biomet lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations.
Zimmer Biomet Announces Third Quarter 2024 Financial Results
Third quarter net sales of $1.824 billion increased 4.0% and 4.1% on a constant currency1 basis Third quarter diluted earnings per share were $1.23; adjusted1 diluted earnings per share were $1.74 Com...
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI® and HAMMR™ Automated Hip Impaction System WARSAW, Ind. , Oct. 28, 2024 /PRNewswire/ -- Zimm...
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
WARSAW, Ind. , Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, October 30, 2024 a...